We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The European Commission (EC) has proposed a targeted amendment to intellectual property rules covering pharmaceuticals to improve the existing system and eliminate competitive disadvantage for manufacturers in the European Union (EU).